These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 24324573)
1. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573 [TBL] [Abstract][Full Text] [Related]
2. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846 [TBL] [Abstract][Full Text] [Related]
3. What can we learn from hepatitis B virus clinical cohorts? Lin CL; Tseng TC; Kao JH Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093 [TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B REVEALed. Chen CJ; Yang HI J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729 [TBL] [Abstract][Full Text] [Related]
5. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa. Makondo E; Bell TG; Kramvis A PLoS One; 2012; 7(9):e46345. PubMed ID: 23029487 [TBL] [Abstract][Full Text] [Related]
6. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691 [TBL] [Abstract][Full Text] [Related]
7. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393 [TBL] [Abstract][Full Text] [Related]
8. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center. Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. Thumbiran NV; Moodley D; Parboosing R; Moodley P S Afr Med J; 2014 Apr; 104(4):307-9. PubMed ID: 25118561 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa. Mthethwa L; Parboosing R; Msomi N BMC Infect Dis; 2024 Aug; 24(1):833. PubMed ID: 39148016 [TBL] [Abstract][Full Text] [Related]
11. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A; J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828 [TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450 [TBL] [Abstract][Full Text] [Related]
13. Perspectives and control of hepatitis B virus infection in Taiwan. Lin CL; Kao JH J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565 [TBL] [Abstract][Full Text] [Related]
14. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ; Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622 [TBL] [Abstract][Full Text] [Related]
15. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922 [TBL] [Abstract][Full Text] [Related]
16. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran. Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739 [TBL] [Abstract][Full Text] [Related]
18. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus. Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study. Park YM; Lee SG World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]